Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Control Bionics Ltd. ( (AU:CBL) ) has issued an announcement.
Control Bionics Limited reported a 14.84% increase in revenues to $6,144,907 for the year ending June 30, 2025, despite a 3.30% rise in losses, totaling $6,108,667. The company did not declare any dividends, and its net tangible assets per ordinary security decreased from 0.93 cents to 0.49 cents. The financial statements highlight a material uncertainty regarding the company’s ability to continue as a going concern, which may impact stakeholders’ confidence.
More about Control Bionics Ltd.
Control Bionics Limited operates in the assistive technology industry, focusing on developing and providing innovative communication and control devices for individuals with disabilities. The company is known for its products that enable users to communicate and interact with technology using neural signals, catering primarily to the healthcare and rehabilitation markets.
Average Trading Volume: 152,197
Technical Sentiment Signal: Sell
Current Market Cap: A$11.2M
Find detailed analytics on CBL stock on TipRanks’ Stock Analysis page.